Ken Griffin Liquidia Corp Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Liquidia Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 217,400 shares of LQDA stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

217,400

Previous 162,900 33.46%

Holding current value

$2.2 Million

Previous $1.95 Million 11.26%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.9 - $14.11 $1.31 Million - $2.08 Million	147,444 New	147,444 $1.47 Million
Q1 2024 May 15, 2024	SELL	$11.35 - $16.73 $261,322 - $385,191	-23,024 Reduced 79.3%	6,010 $88,000
Q4 2023 Feb 14, 2024	SELL	$5.77 - $12.19 $202,330 - $427,454	-35,066 Reduced 54.71%	29,034 $349,000
Q3 2023 Nov 14, 2023	BUY	$6.27 - $8.15 $100,219 - $130,269	15,984 Added 33.22%	64,100 $406,000
Q2 2023 Aug 14, 2023	BUY	$6.63 - $9.9 $309,793 - $462,587	46,726 Added 3361.58%	48,116 $377,000
Q1 2023 May 15, 2023	BUY	$5.72 - $7.91 $7,950 - $10,994	1,390 New	1,390 $9,000
Q3 2022 Nov 14, 2022	SELL	$3.73 - $8.39 $1.15 Million - $2.59 Million	-308,722 Reduced 69.12%	137,952 $750,000
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $1.13 Million - $2.54 Million	-336,728 Reduced 42.98%	446,674 $1.95 Million
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $3.73 Million - $5.36 Million	725,911 Added 1262.65%	783,402 $5.63 Million
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $118,952 - $226,931	43,894 Added 322.82%	57,491 $279,000
Q3 2021 Nov 15, 2021	SELL	$2.28 - $2.95 $54,138 - $70,047	-23,745 Reduced 63.59%	13,597 $37,000
Q2 2021 Aug 16, 2021	SELL	$2.51 - $3.11 $131,388 - $162,796	-52,346 Reduced 58.36%	37,342 $106,000
Q1 2021 May 17, 2021	BUY	$2.42 - $3.6 $155,685 - $231,598	64,333 Added 253.73%	89,688 $241,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $7,503 - $16,709	-2,886 Reduced 10.22%	25,355 $75,000
Q3 2020 Nov 16, 2020	SELL	$4.34 - $8.28 $4.87 Million - $9.29 Million	-1,121,427 Reduced 97.54%	28,241 $139,000
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $5.29 Million - $12.5 Million	1,088,363 Added 1775.33%	1,149,668 $9.68 Million
Q1 2020 May 15, 2020	BUY	$3.31 - $7.15 $56,879 - $122,865	17,184 Added 38.95%	61,305 $289,000
Q4 2019 Feb 14, 2020	SELL	$3.07 - $5.11 $472 - $786	-154 Reduced 0.35%	44,121 $189,000
Q3 2019 Nov 14, 2019	SELL	$3.29 - $8.24 $52,330 - $131,065	-15,906 Reduced 26.43%	44,275 $157,000
Q2 2019 Aug 14, 2019	SELL	$7.92 - $11.39 $406,208 - $584,181	-51,289 Reduced 46.01%	60,181 $481,000
Q1 2019 May 15, 2019	BUY	$10.82 - $21.79 $1.21 Million - $2.43 Million	111,470 New	111,470 $0

Others Institutions Holding LQDA

# of Institutions

171

Shares Held

44.3M

Call Options Held

1.55M

Put Options Held

1.52M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $651M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account